BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8156249)

  • 1. "Fatigue and malaise" as a quality-of-life indicator in small-cell lung cancer patients. The Swiss Group for Clinical Cancer Research (SAKK).
    Hürny C; Bernhard J; Joss R; Schatzmann E; Cavalli F; Brunner K; Alberto P; Senn HJ; Metzger U
    Support Care Cancer; 1993 Nov; 1(6):316-20. PubMed ID: 8156249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of quality of life assessment in a randomized phase III trial of small cell lung cancer--a lesson from the real world--the Swiss Group for Clinical Cancer Research SAKK.
    Hürny C; Bernhard J; Joss R; Willems Y; Cavalli F; Kiser J; Brunner K; Favre S; Alberto P; Glaus A
    Ann Oncol; 1992 Dec; 3(10):825-31. PubMed ID: 1337466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial prognostic factors in small-cell lung cancer patients predicting quality of life during chemotherapy. Swiss Group for Clinical Cancer Research (SAKK).
    Bernhard J; Hürny C; Bacchi M; Joss RA; Cavalli F; Senn HJ; Leyvraz S; Stahel R; Ludwig C; Alberto P
    Br J Cancer; 1996 Nov; 74(10):1660-7. PubMed ID: 8932352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life.
    Bergman B; Aaronson NK; Ahmedzai S; Kaasa S; Sullivan M
    Eur J Cancer; 1994; 30A(5):635-42. PubMed ID: 8080679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of sleep disturbance in lung cancer patients: relationship between sleep disturbance and pain, fatigue, quality of life, and psychological distress.
    Nishiura M; Tamura A; Nagai H; Matsushima E
    Palliat Support Care; 2015 Jun; 13(3):575-81. PubMed ID: 24524428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in patients with lung cancer: a review of literature from 1970 to 1995.
    Montazeri A; Gillis CR; McEwen J
    Chest; 1998 Feb; 113(2):467-81. PubMed ID: 9498968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life during chemotherapy for small cell lung cancer. II. A longitudinal study of the EORTC Core Quality of Life Questionnaire and comparison with the Sickness Impact Profile.
    Bergman B; Sullivan M; Sörenson S
    Acta Oncol; 1992; 31(1):19-28. PubMed ID: 1316770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric properties and measurement equivalence of the Multidimensional Fatigue Syndrome Inventory- Short Form (MFSI-SF) amongst breast cancer and lymphoma patients in Singapore.
    Chan A; Lew C; Wang XJ; Ng T; Chae JW; Yeo HL; Shwe M; Gan YX
    Health Qual Life Outcomes; 2018 Jan; 16(1):20. PubMed ID: 29351803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of structured nursing assessment of symptom distress in advanced lung cancer.
    Sarna L
    Oncol Nurs Forum; 1998 Jul; 25(6):1041-8. PubMed ID: 9679262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in small-cell lung cancer.
    Hickish TF; Smith IE; Nicolson MC; Ashley S; Priest K; Spencer L; Norman A; Middleton G; O'Brien ME
    Br J Cancer; 1998 Jun; 77(11):1966-70. PubMed ID: 9667676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life, symptom status and physical performance in patients with advanced non-small cell lung cancer undergoing chemotherapy: an exploratory analysis of secondary data.
    Shallwani SM; Simmonds MJ; Kasymjanova G; Spahija J
    Lung Cancer; 2016 Sep; 99():69-75. PubMed ID: 27565917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-cell lung cancer patients are just 'a little bit' tired: response shift and self-presentation in the measurement of fatigue.
    Westerman MJ; The AM; Sprangers MA; Groen HJ; van der Wal G; Hak T
    Qual Life Res; 2007 Jun; 16(5):853-61. PubMed ID: 17450423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial.
    Paccagnella A; Favaretto A; Oniga F; Barbieri F; Ceresoli G; Torri W; Villa E; Verusio C; Cetto GL; Santo A; De Pangher V; Artioli F; Cacciani GC; Parodi G; Soresi F; Ghi MG; Morabito A; Biason R; Giusto M; Mosconi P; Chiarion Sileni V;
    Lung Cancer; 2004 Jan; 43(1):83-91. PubMed ID: 14698542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health related quality of life, mood disorders and coping abilities in an unselected sample of patients with primary lung cancer.
    Rolke HB; Bakke PS; Gallefoss F
    Respir Med; 2008 Oct; 102(10):1460-7. PubMed ID: 18590954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party.
    Bleehen NM; Girling DJ; Machin D; Stephens RJ
    Br J Cancer; 1993 Dec; 68(6):1157-66. PubMed ID: 7505104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life results from a randomized, double-blinded, placebo-controlled, multi-center phase III trial of anlotinib in patients with advanced non-small cell lung cancer.
    Si X; Zhang L; Wang H; Zhang X; Wang M; Han B; Li K; Wang Q; Shi J; Wang Z; Cheng Y; He J; Shi Y; Chen W; Wang X; Luo Y; Nan K; Jin F; Li B; Chen Y; Zhou J; Wang D
    Lung Cancer; 2018 Aug; 122():32-37. PubMed ID: 30032842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of fatigue in routine care on a Multidimensional Health Assessment Questionnaire (MDHAQ): a cross-sectional study of associations with RAPID3 and other variables in different rheumatic diseases.
    Castrejon I; Nikiphorou E; Jain R; Huang A; Block JA; Pincus T
    Clin Exp Rheumatol; 2016; 34(5):901-909. PubMed ID: 27382923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the receiving end--II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapy.
    Coates A; Dillenbeck CF; McNeil DR; Kaye SB; Sims K; Fox RM; Woods RL; Milton GW; Solomon J; Tattersall MH
    Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1633-7. PubMed ID: 6315445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life during chemotherapy for small cell lung cancer. I. An evaluation with generic health measures.
    Bergman B; Sullivan M; Sörenson S
    Acta Oncol; 1991; 30(8):947-57. PubMed ID: 1663774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.